表紙
市場調查報告書

免疫測量試劑、設備的全球市場:產業趨勢與未來預測 (到2027年)

Global Immunoassay Reagents and Devices Market - Industry Trends and Forecast To 2027

出版商 Data Bridge Market Research Private Limited 商品編碼 921296
出版日期 內容資訊 英文 316 Pages
商品交期: 最快1-2個工作天內
價格
免疫測量試劑、設備的全球市場:產業趨勢與未來預測 (到2027年) Global Immunoassay Reagents and Devices Market - Industry Trends and Forecast To 2027
出版日期: 2019年12月01日內容資訊: 英文 316 Pages
簡介

全球免疫測量試劑、設備的市場在2020年到2027年預測將完成大幅度的成長。

本報告提供全球免疫測量 (免疫分析法) 用試劑及設備的市場相關分析,市場基本結構和促進、阻礙因素,整體市場規模趨勢預測,各產品、各平台、各手法、各檢體、各用途、各終端用戶、各地區的詳細趨勢,市場競爭環境,主要企業簡介等調查。

第1章 簡介

第2章 市場區隔

第3章 摘要整理

第4章 重要考察

  • 產業分析

第5章 市場概要

  • 推動市場要素
    • 患病人數的增加
    • 藥物篩檢實驗的利用增加
    • 醫療費的增加
    • 免疫測量的廣泛用途
  • 市場阻礙因素
    • 免疫測量用套件、設備的產品回收
    • 法規當局的嚴格法規
    • 設備的相關成本高
  • 市場機會
    • 研究開發 (R&D) 活動的擴大
    • 各企業的策略性舉措
    • 生物科技的技術創新/進步
  • 課題
    • 技術的使用相關認識不足和技術的缺乏
    • 免疫測量的實施的複雜
    • 替代品的可得性

第6章 全球免疫測量試劑、設備市場:各產品

  • 概要
  • 試劑、套件
    • 酵素結合免疫吸附檢測法 (ELIZA) 用試劑、套件
    • 酵素結合免疫地點 (ELISPOT) 用試劑、套件
    • 快速診斷用試劑、套件
    • 西方墨點用試劑、套件
    • 其他
  • 分析設備
    • 各類型
    • 設備的各類型

第7章 全球免疫測量試劑、設備市場:各平台

  • 概要
  • 酵素免疫分析法
  • 螢光免疫分析法
  • 化學分子冷光免疫檢測
  • 輻射免疫檢測 (RIA)
  • 其他

第8章 全球免疫測量試劑、設備市場:各手法

  • 概要
  • 酵素結合免疫吸附檢測法 (ELIZA)
  • 酵素結合免疫地點 (ELISPOT)
  • 迅速檢驗
  • 西方墨點
  • 免疫PCR
  • 其他技術

第6章 全球免疫測量試劑、設備市場:檢體的各類型

  • 概要
  • 血液
  • 尿
  • 唾液
  • 其他

第10章 全球免疫測量試劑、設備市場:各用途

  • 概要
  • 腫瘤、內分泌
  • 血液檢驗
  • 心臟病
  • 感染疾病
  • 骨礦物質代謝障礙
  • 自體免疫疾病
  • 毒物
  • 新生兒篩檢
  • 其他

第11章 全球免疫測量試劑、設備市場:各終端用戶

  • 概要
  • 製藥/生物科技企業
  • 臨床檢驗室
  • 醫院
  • 研究機關、學術研究室
  • 血庫
  • 其他

第12章 全球免疫測量試劑、設備市場:各地區

  • 概要
  • 北美
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 荷蘭
    • 瑞士
    • 比利時
    • 土耳其
    • 其他
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 馬來西亞
    • 新加坡
    • 泰國
    • 印尼
    • 菲律賓
    • 其他
  • 南美
    • 巴西
    • 阿根廷
    • 其他
  • 中東、非洲
    • 沙烏地阿拉伯
    • 南非
    • 埃及
    • 阿拉伯聯合大公國 (UAE)
    • 以色列
    • 其他

第13章 全球免疫測量試劑、設備市場:企業環境

  • 各企業佔有率分析:全球市場
  • 各企業佔有率分析:北美市場
  • 各企業佔有率分析:歐洲市場
  • 各企業佔有率分析:亞太地區市場

第14章 企業簡介

  • F. HOFFMANN-LA ROCHE LTD
    • 公司概要
    • 市場收益額分析
    • 各企業市場佔有率分析
    • 產品系列
    • 最近的趨勢
  • BIO-RAD LABORATORIES, INC.
  • BIOMERIEUX SA
  • ABBOTT
  • RANDOX LABORATORIES LTD.
  • AGILENT TECHNOLOGIES, INC.
  • LUMINEX CORPORATION
  • BD
  • BECKMAN COULTER, INC.
  • BIOCHECK, INC.
  • BIO-TECHNE
  • DIASORIN S.P.A.
  • MERCK KGAA
  • MESO SCALE DIAGNOSTICS, LLC
  • ORTHO CLINICAL DIAGNOSTICS (CARLYLE INVESTMENT MANAGEMENT L.L.C子公司)
  • PERKINELMER INC.
  • QIAGEN
  • QUIDEL CORPORATION
  • SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.
  • SIEMENS
  • Sysmex
  • THERMO FISHER SCIENTIFIC INC.

第15章 調查票

第16章 相關分析

目錄

Global immunoassay reagents and devices market is projected to register a substantial in the forecast period 2020 to 2027. The new market report contains data for historic years 2019, the base year of calculation is 2019 and the forecast period is 2020 to 2027.

Market Segmentation

By Product (Reagents & Kits, Analyzers), Platform (Enzyme Immunoassay, Fluorescence Immunoassays, Chemiluminescence Immunoassays, Radioimmunoassays, Others), Technique (Enzyme-Linked Immunosorbent Assays, Enzyme-Linked Immunospot, Rapid Tests, Western Blotting, Immuno-PCR, Other), Specimen Type (Blood, Urine, Saliva, Others), Application (Oncology and Endocrinology, Hematology & Blood Screening, Cardiology, Infectious Diseases, Bone & Mineral Disorders, Autoimmune Disorders, Toxicology, Neonatal Screening, Other Applications), End User (Pharmaceutical And BioTechnique Companies, Clinical Laboratories, Hospitals, Research & Academic Laboratories, Blood Banks, Others), Country (U.S., Canada, Mexico, Brazil, Argentina, Rest of South America, Germany, France, U.K., Netherlands, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel South Africa, Rest of Middle East and Africa), Market Trends and Forecast to 2027

Some of the major factors contributing to the growth of global immunoassay reagents and devices market:

  • Increasing prevalence of diseases
  • Increasing application of drug screening tests

Market Players

The key market players for global immunoassay reagents and devices market are listed below:

  • F. Hoffmann-La Roche Ltd
  • Siemens
  • Randox Laboratories Ltd
  • Abbott, Bio-Rad Laboratories, Inc
  • Merck KGaA
  • Beckman Coulter, Inc (a subsidiary of Danaher)
  • Sysmex Corporation
  • bioMerieux SA
  • Thermo Fisher Scientific, Inc
  • BD
  • Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • DiaSorin S.p.A
  • Ortho Clinical Diagnostics (a subsidiary of Carlyle Investment Management L.L.C)
  • QIAGEN
  • Quidel Corporation
  • BioCheck, Inc
  • Bio-Techne
  • PerkinElmer Inc
  • Agilent Technologies, Inc
  • Luminex Corporation
  • MESO SCALE DIAGNOSTICS, LLC

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 OBJECTIVES OF THE STUDY
  • 1.2 MARKET DEFINITION
  • 1.3 OVERVIEW OF GLOBAL IMMUNOASSAY REAGENTS AND DEVICES MARKET
  • 1.4 CURRENCY AND PRICING
  • 1.5 LIMITATIONS
  • 1.6 MARKETS COVERED

2 MARKET SEGMENTATION

  • 2.1 MARKETS COVERED
  • 2.2 GEOGRAPHICAL SCOPE
  • 2.3 YEARS CONSIDERED FOR THE STUDY
  • 2.4 DBMR TRIPOD DATA VALIDATION MODEL
  • 2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
  • 2.6 DBMR MARKET POSITION GRID
  • 2.7 DBMR VENDOR SHARE ANALYSIS
  • 2.8 MULTIVARIATE MODELING
  • 2.9 PRODUCT TIMELINE CURVE
  • 2.10 SECONDARY SOURCES
  • 2.11 ASSUMPTIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

  • 4.1 INDUSTRY INSIGHT

5 MARKET OVERVIEW

  • 5.1 DRIVERS
    • 5.1.1 INCREASING PREVALENCE OF DISEASES
    • 5.1.2 INCREASING APPLICATION OF DRUG SCREEINING TESTS
    • 5.1.3 INCREASING HEALTHCARE EXPENDITURE
    • 5.1.4 WIDE APPLICATION OF IMMUNOASSAY
  • 5.2 RESTRAINTS
    • 5.2.1 PRODUCT RECALL OF IMMUNOASSAY KITS AND DEVICES
    • 5.2.2 STRINGENT REGULATIONS BY REGULATORY AUTHORITIES
    • 5.2.3 HIGH COST ASSOCIATED WITH DEVICES
  • 5.3 OPPORTUNITIES
    • 5.3.1 INCREASE IN RESEARCH & DEVELOPMENT ACTIVITIES
    • 5.3.2 STRATEGIC INITATIVES BY THE COMPANIES
    • 5.3.3 TECHNOLOGICAL UPGRADATION AND ADVANCEMENTS IN BIOTECHNOLOGY
  • 5.4 CHALLENGES
    • 5.4.1 LACK OF AWARENESS AND SKILLS REGARDING THE USAGE OF TECHNOLOGY
    • 5.4.2 COMPLEXICITY IN PERFORMING IMMUNOASSAY
    • 5.4.3 AVAILABILITY OF SUBSTITUTE

6 GLOBAL IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY PRODUCT

  • 6.1 OVERVIEW
  • 6.2 REAGENTS & KITS
    • 6.2.1 ELISA REAGENTS & KITS
      • 6.2.1.1 THIRD-GENERATION ELISA
      • 6.2.1.2 FIFTH-GENERATION ELISA
      • 6.2.1.3 FOURTH-GENERATION ELISA
      • 6.2.1.4 FIRST-GENERATION ELISA
      • 6.2.1.5 SECOND-GENERATION ELISA
    • 6.2.2 ELISPOT REAGENTS & KITS
    • 6.2.3 RAPID TEST REAGENTS & KITS
    • 6.2.4 WESTERN BLOT REAGENTS & KITS
    • 6.2.5 OTHER REAGENTS & KITS
  • 6.3 ANALYZERS
    • 6.3.1 BY TYPE
      • 6.3.1.1 OPEN-ENDED SYSTEMS
      • 6.3.1.2 CLOSED-ENDED SYSTEMS
    • 6.3.2 BY DEVICE TYPE
      • 6.3.2.1 BENCH-TOP
      • 6.3.2.2 FLOOR STANDING

7 GLOBAL IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY PLATFORM

  • 7.1 OVERVIEW
  • 7.2 ENZYME IMMUNOASSAY
  • 7.3 FLUORESCENCE IMMUNOASSAYS
  • 7.4 CHEMILUMINESCENCE IMMUNOASSAYS
  • 7.5 RADIOIMMUNOASSAYS
  • 7.6 OTHERS

8 GLOBAL IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TECHNIQUE

  • 8.1 OVERVIEW
  • 8.2 ENZYME-LINKED IMMUNOSORBENT ASSAYS
  • 8.3 ENZYME-LINKED IMMUNOSPOT
  • 8.4 RAPID TESTS
  • 8.5 WESTERN BLOTTING
  • 8.6 IMMUNO-PCR
  • 8.7 OTHER TECHNIQUES

9 GLOBAL IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY SPECIMEN TYPE

  • 9.1 OVERVIEW
  • 9.2 BLOOD
  • 9.3 URINE
  • 9.4 SALIVA
  • 9.5 OTHERS

10 GLOBAL IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY APPLICATION

  • 10.1 OVERVIEW
  • 10.2 ONCOLOGY AND ENDOCRINOLOGY
  • 10.3 HEMATOLOGY & BLOOD SCREENING
  • 10.4 CARDIOLOGY
  • 10.5 INFECTIOUS DISEASES
  • 10.6 BONE & MINERAL DISORDERS
  • 10.7 AUTOIMMUNE DISORDERS
  • 10.8 TOXICOLOGY
  • 10.9 NEONATAL SCREENING
  • 10.10 OTHER APPLICATIONS

11 GLOBAL IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY END USER

  • 11.1 OVERVIEW
  • 11.2 PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES
  • 11.3 CLINICAL LABORATORIES
  • 11.4 HOSPITALS
  • 11.5 RESEARCH & ACADEMIC LABORATORIES
  • 11.6 BLOOD BANKS
  • 11.7 OTHERS

12 GLOBAL IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY GEOGRAPHY

  • 12.1 OVERVIEW
  • 12.2 NORTH AMERICA
    • 12.2.1 U.S.
    • 12.2.2 CANADA
    • 12.2.3 MEXICO

  • 12.3 EUROPE
    • 12.3.1 GERMANY
    • 12.3.2 FRANCE
    • 12.3.3 U.K.
    • 12.3.4 ITALY
    • 12.3.5 SPAIN
    • 12.3.6 RUSSIA
    • 12.3.7 NETHERLANDS
    • 12.3.8 SWITZERLAND
    • 12.3.9 BELGIUM
    • 12.3.10 TURKEY
    • 12.3.11 REST OF EUROPE
  • 12.4 ASIA-PACIFIC
    • 12.4.1 CHINA
    • 12.4.2 JAPAN
    • 12.4.3 INDIA
    • 12.4.4 SOUTH KOREA
    • 12.4.5 AUSTRALIA
    • 12.4.6 MALAYSIA
    • 12.4.7 SINGAPORE
    • 12.4.8 THAILAND
    • 12.4.9 INDONESIA
    • 12.4.10 PHILIPPINES
    • 12.4.11 REST OF ASIA-PACIFIC
  • 12.5 SOUTH AMERICA
    • 12.5.1 BRAZIL
    • 12.5.2 ARGENTINA
    • 12.5.3 REST OF SOUTH AMERICA
  • 12.6 MIDDLE EAST & AFRICA
    • 12.6.1 SAUDI ARABIA
    • 12.6.2 SOUTH AFRICA
    • 12.6.3 EGYPT
    • 12.6.4 UAE
    • 12.6.5 ISRAEL
    • 12.6.6 REST OF MIDDLE EAST & AFRICA

13 GLOBAL IMMUNOASSAY REAGENTS AND DEVICES MARKET, COMPANY LANDSCAPE

  • 13.1 COMPANY SHARE ANALYSIS: GLOBAL
  • 13.2 COMPANY SHARE ANALYSIS: NORTH AMERICA
  • 13.3 COMPANY SHARE ANALYSIS: EUROPE
  • 13.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC

14 COMPANY PROFILES

  • 14.1 F. HOFFMANN-LA ROCHE LTD
    • 14.1.1 COMPANY SNAPSHOT
    • 14.1.2 REVENUE ANALYSIS
    • 14.1.3 COMPANY SHARE ANALYSIS
    • 14.1.4 PRODUCT PORTFOLIO
    • 14.1.5 RECENT DEVELOPMENT
  • 14.2 BIO-RAD LABORATORIES, INC.
    • 14.2.1 COMPANY SNAPSHOT
    • 14.2.2 REVENUE ANALYSIS
    • 14.2.3 COMPANY SHARE ANALYSIS
    • 14.2.4 PRODUCT PORTFOLIO
    • 14.2.5 RECENT DEVELOPMENTS
  • 14.3 BIOMERIEUX SA
    • 14.3.1 COMPANY SNAPSHOT
    • 14.3.2 REVENUE ANALYSIS
    • 14.3.3 COMPANY SHARE ANALYSIS
    • 14.3.4 PRODUCT PORTFOLIO
    • 14.3.5 RECENT DEVELOPMENT
  • 14.4 ABBOTT
    • 14.4.1 COMPANY SNAPSHOT
    • 14.4.2 REVENUE ANALYSIS
    • 14.4.3 COMPANY SHARE ANALYSIS
    • 14.4.4 PRODUCT PORTFOLIO
    • 14.4.5 RECENT DEVELOPMENTS
  • 14.5 RANDOX LABORATORIES LTD.
    • 14.5.1 COMPANY SNAPSHOT
    • 14.5.2 PRODUCT PORTFOLIO
    • 14.5.3 RECENT DEVELOPMENT
  • 14.6 AGILENT TECHNOLOGIES, INC.
    • 14.6.1 COMPANY SNAPSHOT
    • 14.6.2 REVENUE ANALYSIS
    • 14.6.3 PRODUCT PORTFOLIO
    • 14.6.4 RECENT DEVELOPMENT
  • 14.7 LUMINEX CORPORATION
    • 14.7.1 COMPANY SNAPSHOT
    • 14.7.2 REVENUE ANALYSIS
    • 14.7.3 PRODUCT PORTFOLIO
    • 14.7.4 RECENT DEVELOPMENT
  • 14.8 BD
    • 14.8.1 COMPANY SNAPSHOT
    • 14.8.2 REVENUE ANALYSIS
    • 14.8.3 PRODUCT PORTFOLIO
    • 14.8.4 RECENT DEVELOPMENT
  • 14.9 BECKMAN COULTER, INC.
    • 14.9.1 COMPANY SNAPSHOT
    • 14.9.2 REVENUE ANALYSIS
    • 14.9.3 PRODUCT PORTFOLIO
    • 14.9.4 RECENT DEVELOPMENT
  • 14.10 BIOCHECK, INC.
    • 14.10.1 COMPANY SNAPSHOT
    • 14.10.2 PRODUCT PORTFOLIO
    • 14.10.3 RECENT DEVELOPMENT
  • 14.11 BIO-TECHNE
    • 14.11.1 COMPANY SNAPSHOT
    • 14.11.2 REVENUE ANALYSIS
    • 14.11.3 PRODUCT PORTFOLIO
    • 14.11.4 RECENT DEVELOPMENTS
  • 14.12 DIASORIN S.P.A.
    • 14.12.1 COMPANY SNAPSHOT
    • 14.12.2 PRODUCT PORTFOLIO
    • 14.12.3 RECENT DEVELOPMENTS
  • 14.13 MERCK KGAA
    • 14.13.1 COMPANY SNAPSHOT
    • 14.13.2 REVENUE ANALYSIS
    • 14.13.3 PRODUCT PORTFOLIO
    • 14.13.4 RECENT DEVELOPMENTS
  • 14.14 MESO SCALE DIAGNOSTICS, LLC
    • 14.14.1 COMPANY SNAPSHOT
    • 14.14.2 PRODUCT PORTFOLIO
    • 14.14.3 RECENT DEVELOPMENTS
  • 14.15 ORTHO CLINICAL DIAGNOSTICS (A SUBSIDIARY OF CARLYLE INVESTMENT MANAGEMENT L.L.C)
    • 14.15.1 COMPANY SNAPSHOT
    • 14.15.2 REVENUE ANALYSIS
    • 14.15.3 PRODUCT PORTFOLIO
    • 14.15.4 RECENT DEVELOPMENT
  • 14.16 PERKINELMER INC.
    • 14.16.1 COMPANY SNAPSHOT
    • 14.16.2 REVENUE ANALYSIS
    • 14.16.3 PRODUCT PORTFOLIO
    • 14.16.4 RECENT DEVELOPMENT
  • 14.17 QIAGEN
    • 14.17.1 COMPANY SNAPSHOT
    • 14.17.2 REVENUE ANALYSIS
    • 14.17.3 PRODUCT PORTFOLIO
    • 14.17.4 RECENT DEVELOPMENT
  • 14.18 QUIDEL CORPORATION
    • 14.18.1 COMPANY SNAPSHOT
    • 14.18.2 REVENUE ANALYSIS
    • 14.18.3 PRODUCT PORTFOLIO
    • 14.18.4 RECENT DEVELOPMENT
  • 14.19 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.
    • 14.19.1 COMPANY SNAPSHOT
    • 14.19.2 PRODUCT PORTFOLIO
    • 14.19.3 RECENT DEVELOPMENTS
  • 14.20 SIEMENS
    • 14.20.1 COMPANY SNAPSHOT
    • 14.20.2 REVENUE ANALYSIS
    • 14.20.3 PRODUCT PORTFOLIO
    • 14.20.4 RECENT DEVELOPMENTS
  • 14.21 SYSMEX CORPORATION
    • 14.21.1 COMPANY SNAPSHOT
    • 14.21.2 REVENUE ANALYSIS
    • 14.21.3 PRODUCT PORTFOLIO
    • 14.21.4 RECENT DEVELOPMENTS
  • 14.22 THERMO FISHER SCIENTIFIC INC.
    • 14.22.1 COMPANY SNAPSHOT
    • 14.22.2 REVENUE ANALYSIS
    • 14.22.3 PRODUCT PORTFOLIO
    • 14.22.4 RECENT DEVELOPMENTS

15 QUESTIONNAIRE

16 RELATED REPORTS

LIST OF FIGURES

  • FIGURE 1 GLOBAL IMMUNOASSAY REAGENTS AND DEVICES MARKET: SEGMENTATION
  • FIGURE 2 GLOBAL IMMUNOASSAY REAGENTS AND DEVICES MARKET: DATA TRIANGULATION
  • FIGURE 3 GLOBAL IMMUNOASSAY REAGENTS AND DEVICES MARKET: DROC ANALYSIS
  • FIGURE 4 GLOBAL IMMUNOASSAY REAGENTS AND DEVICES MARKET: GLOBAL VS REGIONAL MARKET ANALYSIS
  • FIGURE 5 GLOBAL IMMUNOASSAY REAGENTS AND DEVICES MARKET: COMPANY RESEARCH ANALYSIS
  • FIGURE 6 GLOBAL IMMUNOASSAY REAGENTS AND DEVICES MARKET: INTERVIEW DEMOGRAPHICS
  • FIGURE 7 GLOBAL IMMUNOASSAY REAGENTS AND DEVICES MARKET: DBMR MARKET POSITION GRID
  • FIGURE 8 GLOBAL IMMUNOASSAY REAGENTS AND DEVICES MARKET: DBMR VENDOR SHARE ANALYSIS
  • FIGURE 9 NORTH AMERICA IS EXPECTED TO DOMINATE THE GLOBAL IMMUNOASSAY REAGENTS AND DEVICES MARKET AND ASIA-PACIFIC IS EXPECTED TO GROW WITH THE HIGHEST CAGR IN THE FORECAST PERIOD OF 2020 TO 2027
  • FIGURE 10 GLOBAL IMMUNOASSAY REAGENTS AND DEVICES MARKET: SEGMENTATION
  • FIGURE 11 INCREASING PREVALENCE OF DISEASES AND HIGH HEALTHCARE EXPENDITURE ARE EXPECTED TO DRIVE THE GLOBAL IMMUNOASSAY REAGENTS AND DEVICES MARKET IN THE FORECAST PERIOD OF 2020 TO 2027
  • FIGURE 12 REAGENTS & KITS SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE GLOBAL IMMUNOASSAY REAGENTS AND DEVICES MARKET IN 2020 & 2027
  • FIGURE 13 ASIA-PACIFIC IS THE FASTEST GROWING MARKET FOR IMMUNOASSAY REAGENTS AND DEVICES MANUFACTURERS IN THE FORECAST PERIOD OF 2020 TO 2027
  • FIGURE 14 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGE OF GLOBAL IMMUNOASSAY REAGENTS AND DEVICES MARKET
  • FIGURE 15 HEALTHCARE EXPENDITURE IN FEW COUNTRIES (2015 & 2016)
  • FIGURE 16 GLOBAL IMMUNOASSAY REAGENTS AND DEVICES MARKET: BY PRODUCT, 2019
  • FIGURE 17 GLOBAL IMMUNOASSAY REAGENTS AND DEVICES MARKET: BY PLATFORM, 2019
  • FIGURE 18 GLOBAL IMMUNOASSAY REAGENTS AND DEVICES MARKET: BY TECHNIQUE, 2019
  • FIGURE 19 GLOBAL IMMUNOASSAY REAGENTS AND DEVICES MARKET: BY SPECIMEN TYPE, 2019
  • FIGURE 20 GLOBAL IMMUNOASSAY REAGENTS AND DEVICES MARKET: BY APPLICATION, 2019
  • FIGURE 21 GLOBAL IMMUNOASSAY REAGENTS AND DEVICES MARKET: BY END USER, 2019
  • FIGURE 22 GLOBAL IMMUNOASSAY REAGENTS AND DEVICES MARKET: SNAPSHOT (2019)
  • FIGURE 23 GLOBAL IMMUNOASSAY REAGENTS AND DEVICES MARKET: BY GEOGRAPHY (2019)
  • FIGURE 24 GLOBAL IMMUNOASSAY REAGENTS AND DEVICES MARKET: BY GEOGRAPHY (2020 & 2027)
  • FIGURE 25 GLOBAL IMMUNOASSAY REAGENTS AND DEVICES MARKET: BY GEOGRAPHY (2019 & 2027)
  • FIGURE 26 GLOBAL IMMUNOASSAY REAGENTS AND DEVICES MARKET: BY PRODUCT (2020-2027)
  • FIGURE 27 NORTH AMERICA IMMUNOASSAY REAGENTS AND DEVICES MARKET: SNAPSHOT (2019)
  • FIGURE 28 NORTH AMERICA IMMUNOASSAY REAGENTS AND DEVICES MARKET: BY COUNTRY (2019)
  • FIGURE 29 NORTH AMERICA IMMUNOASSAY REAGENTS AND DEVICES MARKET: BY COUNTRY (2020 & 2027)
  • FIGURE 30 NORTH AMERICA IMMUNOASSAY REAGENTS AND DEVICES MARKET: BY COUNTRY (2019 & 2027)
  • FIGURE 31 NORTH AMERICA IMMUNOASSAY REAGENTS AND DEVICES MARKET: BY PRODUCT (2020-2027)
  • FIGURE 32 EUROPE IMMUNOASSAY REAGENTS AND DEVICES MARKET: SNAPSHOT (2019)
  • FIGURE 33 EUROPE IMMUNOASSAY REAGENTS AND DEVICES MARKET: BY COUNTRY (2019)
  • FIGURE 34 EUROPE IMMUNOASSAY REAGENTS AND DEVICES MARKET: BY COUNTRY (2020 & 2027)
  • FIGURE 35 EUROPE IMMUNOASSAY REAGENTS AND DEVICES MARKET: BY COUNTRY (2019 & 2027)
  • FIGURE 36 EUROPE IMMUNOASSAY REAGENTS AND DEVICES MARKET: BY PRODUCT (2020-2027)
  • FIGURE 37 ASIA-PACIFIC IMMUNOASSAY REAGENTS AND DEVICES MARKET: SNAPSHOT (2019)
  • FIGURE 38 ASIA-PACIFIC IMMUNOASSAY REAGENTS AND DEVICES MARKET: BY COUNTRY (2019)
  • FIGURE 39 ASIA-PACIFIC IMMUNOASSAY REAGENTS AND DEVICES MARKET: BY COUNTRY (2020 & 2027)
  • FIGURE 40 ASIA-PACIFIC IMMUNOASSAY REAGENTS AND DEVICES MARKET: BY COUNTRY (2019 & 2027)
  • FIGURE 41 ASIA-PACIFIC IMMUNOASSAY REAGENTS AND DEVICES MARKET: BY PRODUCT (2020-2027)
  • FIGURE 42 SOUTH AMERICA IMMUNOASSAY REAGENTS AND DEVICES MARKET: SNAPSHOT (2019)
  • FIGURE 43 SOUTH AMERICA IMMUNOASSAY REAGENTS AND DEVICES MARKET: BY COUNTRY (2019)
  • FIGURE 44 SOUTH AMERICA IMMUNOASSAY REAGENTS AND DEVICES MARKET: BY COUNTRY (2020 & 2027)
  • FIGURE 45 SOUTH AMERICA IMMUNOASSAY REAGENTS AND DEVICES MARKET: BY COUNTRY (2019 & 2027)
  • FIGURE 46 SOUTH AMERICA IMMUNOASSAY REAGENTS AND DEVICES MARKET: BY PRODUCT (2020-2027)
  • FIGURE 47 MIDDLE EAST & AFRICA IMMUNOASSAY REAGENTS AND DEVICES MARKET: SNAPSHOT (2019)
  • FIGURE 48 MIDDLE EAST & AFRICA IMMUNOASSAY REAGENTS AND DEVICES MARKET: BY COUNTRY (2019)
  • FIGURE 49 MIDDLE EAST & AFRICA IMMUNOASSAY REAGENTS AND DEVICES MARKET: BY COUNTRY (2020 & 2027)
  • FIGURE 50 MIDDLE EAST & AFRICA IMMUNOASSAY REAGENTS AND DEVICES MARKET: BY COUNTRY (2019 & 2027)
  • FIGURE 51 MIDDLE EAST & AFRICA IMMUNOASSAY REAGENTS AND DEVICES MARKET: BY PRODUCT (2020-2027)
  • FIGURE 52 GLOBAL IMMUNOASSAY REAGENTS AND DEVICES MARKET: COMPANY SHARE 2019 (%)
  • FIGURE 53 NORTH AMERICA IMMUNOASSAY REAGENTS AND DEVICES MARKET: COMPANY SHARE 2019 (%)
  • FIGURE 54 EUROPE IMMUNOASSAY REAGENTS AND DEVICES MARKET: COMPANY SHARE 2019 (%)
  • FIGURE 55 ASIA-PACIFIC IMMUNOASSAY REAGENTS AND DEVICES MARKET: COMPANY SHARE 2019 (%)